Clinical Trial

Home tDCS for the Treatment of Major Depression.

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this multicentric randomized controlled trial is to compare the effectiveness and safety of home-based tDCS for the treatment of major depression versus tDCS treatment in a healthcare centre, and explore the effects of an accelerated home-tDCS protocol. The change in depression index at the end of treatment, measured with MADRS, will be the primary outcome.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-02
Trial Details
NCT Number NCT07510880
Lead Sponsor Ionclinics & Deionic SL
Collaborators: Hospital Universitari de Bellvitge, Consorci Sanitari del Maresme. Hospital Universitari de Mataró, Parc Taulí Hospital Universitari
Conditions Major Depression Disorder
Enrollment 198 participants
Start Date 2026-04-14
Primary Completion 2027-04-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-01